Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
This on-demand webinar focuses on the regulatory requirements (compliance of actives and labelling obligations) for the marketing of articles treated with biocidal products.
The Biocidal Product Regulation “BPR” (EU no 528/2012) concerning the placing on the market and use of biocidal products, sets rules for the use of articles treated with, or intentionally incorporating, one or more biocidal products. According to the regulation, articles can only be treated with biocidal products containing active substances approved in the EU. This is a change from the Biocidal Products Directive (repealed by the BPR from 1 September 2013), where articles imported from third countries could be treated with substances not approved in the EU.
Companies must be ready to provide the consumers with information about the biocidal treatment of the article they are selling. If a consumer requests information about a treated article, the supplier must provide it free of charge within 45 days. Manufacturers and importers of treated articles also need to ensure that products are labelled according to both the regulation on Classification, Labelling and Packaging and the additional requirements defined by the Biocidal Products Regulation.
Please complete the form below to download the webinar recording.